Fibromyalgia is a clinical syndrome wherein the patient experiences generalized pain and fatigue that cannot be explained by the presence of any other disorder.
It is often considered to be psychosomatic or psychogenic in nature.
It is found in approximately 2% of the population and the prevalence increases with age, most common in women 20-55 year of age

Fibromyalgia Patient Education

Patient Education

  • Critical in the optimal management of fibromyalgia
  • Goal is to help the patient understand and manage the symptoms optimally, reduce dependence on the medical system and work effectively within the system
  • Provide patient and family with information about fibromyalgia, diagnosis and all treatment options
  • It should be emphasized that fibromyalgia is a real disease and is not a deforming or a deteriorating disorder
    • Great majority of patients have normal and active lives
    • Discuss the patient's adherence or nonadherence to the agreed upon treatment strategies and other modalities
    • Confirm the diagnosis in an authoritative manner and reassure patients that they can be helped
  • Emphasize the role of stress and mood disorder, encourage fibromyalgia patients to learn simple relaxation techniques and to consider formal stress-reduction programs
  • Reinforce the importance of proper sleep hygiene
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Rheumatology digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
2 days ago
High-frequency use of cannabis appears to worsen clinical pain and associated symptoms among chronic pain patients, a recent study has found.
Jairia Dela Cruz, 5 days ago
In patients with heart failure with reduced ejection fraction (HFrEF) receiving angiotensin-converting-enzyme (ACE) inhibitors, high dosing confers benefits for the risk of death or hospitalization that are similar to that obtained with lower dosing, according to a systematic review and meta-analysis.
Women with pre-eclampsia are at higher risk of developing heart failure, a study suggests.
06 Sep 2020
Type 2 diabetes mellitus patients taking proton pump inhibitors (PPIs) are at a higher risk of sustaining hip fractures, a recent study has found.